Two dynamin-2 genes are required for normal zebrafish development
- Authors
- Gibbs, E.M., Davidson, A.E., Trickey-Glassman, A., Backus, C., Hong, Y., Sakowski, S.A., Dowling, J.J., and Feldman, E.L.
- ID
- ZDB-PUB-130308-23
- Date
- 2013
- Source
- PLoS One 8(2): e55888 (Journal)
- Registered Authors
- Dowling, Jim
- Keywords
- none
- MeSH Terms
-
- Animals
- Animals, Genetically Modified
- Behavior, Animal/physiology
- Dynamin II/genetics*
- Dynamin II/metabolism
- Motor Activity/physiology
- Muscle, Skeletal/metabolism
- Phenotype
- Zebrafish/genetics*
- Zebrafish/growth & development
- Zebrafish/metabolism
- Zebrafish Proteins/genetics*
- Zebrafish Proteins/metabolism
- PubMed
- 23418470 Full text @ PLoS One
Dynamin-2 (DNM2) is a large GTPase involved in clathrin-mediated endocytosis and related trafficking pathways. Mutations in human DNM2 cause two distinct neuromuscular disorders: centronuclear myopathy and Charcot-Marie-Tooth disease. Zebrafish have been shown to be an excellent animal model for many neurologic disorders, and this system has the potential to inform our understanding of DNM2-related disease. Currently, little is known about the endogenous zebrafish orthologs to human DNM2. In this study, we characterize two zebrafish dynamin-2 genes, dnm2 and dnm2-like. Both orthologs are structurally similar to human DNM2 at the gene and protein levels. They are expressed throughout early development and in all adult tissues examined. Knockdown of dnm2 and dnm2-like gene products resulted in extensive morphological abnormalities during development, and expression of human DNM2 RNA rescued these phenotypes. Our findings suggest that dnm2 and dnm2-like are orthologs to human DNM2, and that they are required for normal zebrafish development.